Literature DB >> 24467261

Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis.

B Afsharimani1, C W Doornebal, P J Cabot, M W Hollmann, M-O Parat.   

Abstract

UNLABELLED: The effect of opioids on tumour growth and metastasis has been debated for many years, with recent emphasis on the possibility that they might influence the rate of disease-free survival after tumour resection when used in the perioperative pain management of cancer surgery patients. The literature presents conflicting and inconclusive in vitro and in vivo data about the potential effect of opioids, especially morphine, on tumour growth and metastasis. To inform clinical practice, appropriate animal models are needed to test whether opioids alter the course of tumour growth and metastasis. Here, we review the literature on animal-based studies testing the effect of morphine on cancer so far, and analyse differences between the models used that may explain the discrepancies in published results. Such analysis should elucidate the role of opioids in cancer and help define ideal pre-clinical models to provide definitive answers. LINKED ARTICLES: This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  animal models; metastasis; morphine; tumour growth

Mesh:

Substances:

Year:  2014        PMID: 24467261      PMCID: PMC4292942          DOI: 10.1111/bph.12589

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  90 in total

1.  Differential tolerance to morphine's immunomodulatory effects following continuous administration.

Authors:  J P West; L A Dykstra; D T Lysle
Journal:  Drug Alcohol Depend       Date:  1998-12-01       Impact factor: 4.492

Review 2.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

3.  Opiate antagonist prevents μ- and δ-opiate receptor dimerization to facilitate ability of agonist to control ethanol-altered natural killer cell functions and mammary tumor growth.

Authors:  Dipak K Sarkar; Amitabha Sengupta; Changqing Zhang; Nadka Boyadjieva; Sengottuvelan Murugan
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

Review 4.  Mouse models of advanced spontaneous metastasis for experimental therapeutics.

Authors:  Giulio Francia; William Cruz-Munoz; Shan Man; Ping Xu; Robert S Kerbel
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 5.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

6.  Enhancement of tumor growth by morphine and its possible mechanism in mice.

Authors:  M Ishikawa; K Tanno; A Kamo; Y Takayanagi; K Sasaki
Journal:  Biol Pharm Bull       Date:  1993-08       Impact factor: 2.233

7.  Species difference of site-selective glucuronidation of morphine.

Authors:  C K Kuo; N Hanioka; Y Hoshikawa; K Oguri; H Yoshimura
Journal:  J Pharmacobiodyn       Date:  1991-04

8.  Expression of opioid peptides in tumors.

Authors:  D G Bostwick; W E Null; D Holmes; E Weber; J D Barchas; K G Bensch
Journal:  N Engl J Med       Date:  1987-12-03       Impact factor: 91.245

9.  Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines.

Authors:  Patrica J Keller; Amy F Lin; Lisa M Arendt; Ina Klebba; Ainsely D Jones; Jenny A Rudnick; Theresa A DiMeo; Hannah Gilmore; Douglas M Jefferson; Roger A Graham; Stephen P Naber; Stuart Schnitt; Charlotte Kuperwasser
Journal:  Breast Cancer Res       Date:  2010-10-21       Impact factor: 6.466

10.  Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.

Authors:  K Boggio; G Nicoletti; E Di Carlo; F Cavallo; L Landuzzi; C Melani; M Giovarelli; I Rossi; P Nanni; C De Giovanni; P Bouchard; S Wolf; A Modesti; P Musiani; P L Lollini; M P Colombo; G Forni
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

View more
  19 in total

1.  Themed section.

Authors:  M J Christie; M Connor; J R Traynor
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

2.  Morphine alters the circulating proteolytic profile in mice: functional consequences on cellular migration and invasion.

Authors:  Nan Xie; Samira Khabbazi; Zeyad D Nassar; Kye Gregory; Tharindu Vithanage; Bela Anand-Apte; Peter J Cabot; David Sturgess; Paul N Shaw; Marie-Odile Parat
Journal:  FASEB J       Date:  2017-08-07       Impact factor: 5.191

Review 3.  Influence of opioids on immune function in patients with cancer pain: from bench to bedside.

Authors:  Jason W Boland; A Graham Pockley
Journal:  Br J Pharmacol       Date:  2017-07-23       Impact factor: 8.739

Review 4.  Exploiting the critical perioperative period to improve long-term cancer outcomes.

Authors:  Maya Horowitz; Elad Neeman; Eran Sharon; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2015-01-20       Impact factor: 66.675

5.  Agonists Specific for κ-Opioid Receptor Induces Apoptosis of HCC Cells Through Enhanced Endoplasmic Reticulum Stress.

Authors:  Mengyuan Tan; Hanyu Wang; Cheng Gao; Zhen Jiang; Ying Yin; Ruyi Xing; Ling Hu; Jiegou Xu; Min Zhang; Yanhu Xie
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

6.  Efficacy of Intrathecal Morphine in a Model of Surgical Pain in Rats.

Authors:  Aurelie Thomas; Amy Miller; Johnny Roughan; Aneesa Malik; Katherine Haylor; Charlotte Sandersen; Paul Flecknell; Matthew Leach
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240

7.  The TLR4-Active Morphine Metabolite Morphine-3-Glucuronide Does Not Elicit Macrophage Classical Activation In Vitro.

Authors:  Samira Khabbazi; Nan Xie; Wenjun Pu; Yannick Goumon; Marie-Odile Parat
Journal:  Front Pharmacol       Date:  2016-11-17       Impact factor: 5.810

Review 8.  Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of β-adrenergic and cyclooxygenase 2 signaling.

Authors:  Itay Ricon; Tsipi Hanalis-Miller; Rita Haldar; Rebecca Jacoby; Shamgar Ben-Eliyahu
Journal:  Cancer       Date:  2018-10-06       Impact factor: 6.921

Review 9.  A systematic review and meta-analysis of the ability of analgesic drugs to reduce metastasis in experimental cancer models.

Authors:  Carlijn R Hooijmans; Florentine J Geessink; Merel Ritskes-Hoitinga; Gert-Jan Scheffer
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

10.  Morphine decreases the pro-angiogenic interaction between breast cancer cells and macrophages in vitro.

Authors:  Samira Khabbazi; Zeyad D Nassar; Yannick Goumon; Marie-Odile Parat
Journal:  Sci Rep       Date:  2016-08-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.